Latest News

Print

Why I Do This?

Dr. Liana Apostolova, Associate Professor of Neurology, David Geffen School of Medicine at UCLA, and Director of Neuroimaging Laboratory, Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was featured in the UCLA 2013 Winter Issue of the Partners in Discovery Department of Neurology Newsletter - "Why I Do This"?

Print

MedScape reports on possible benefits of the “Mediterranean diet” to enhance cognition.

Dr. Zaldy Tan, Associate Professor of Medicine in the Division of Geriatrics, Medical Director of the UCLA Alzheimer's and Dementia Care Program, and a Researcher at the Easton Center for Alzheimer's Disease Research, was interviewed for a Feb. 6 MedScape Today (subscription) article about the possible benefits of the Mediterranean diet (MedDiet), which consists mostly of plant derived foods, and its possible benefits to cognition in later life.

Print

UCLA drug trial hopes to keep early Alzheimer's at bay.

Dr. John Ringman, Associate Clinical Professor of Neurology, David Geffen School of Medicine at UCLA, and Associate Clinical Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA was featured in Feb. 1 Dr. Bruce Hensel's medical report on NBCLA Channel 4 News. Dr. Ringman talked about how rarely, Alzheimer's disease is inherited in a highly genetic fashion in which changes in specific genes have been identified that essentially guarantee the onset of the disease at a relatively young age. Investigators are now using this knowledge to administer promising medications to prevent the disease to persons carrying such genetic alterations to potentially prevent them from manifesting symptoms of the disease. Such trials are being initiated at UCLA and other sites within the next 6 months.

Print

UCLA researchers report promising therapeutic approach for Alzheimer's disease.

Dr. David Teplow, Professor of Neurology, was featured in Jan. 23 Examiner.com and Scrupsreport.com, articles about his research that, for the first time, isolated a unique hairpin-like segment of a toxic protein associated with Alzheimer's disease, that may be a precise target for drug delivery that would slow or stop the disease.

Print

Media notes tribulations of Alzheimer’s clinical trials.

Dr. Joshua Grill, Assistant Professor of Neurology and Director of Education for the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was featured in several outlets regarding his research showing that the outcome of any Alzheimer's clinical trial can be influenced by who the patient's study partner is, whether it's a spouse, adult child, or "other." Coverage included Dec. 19 in the Examiner.com and Science Daily; Dec. 20 in MedPage Today; and Dec. 21 in NewsMedical.net and Labmate Online.